A detailed history of Swedbank Ab transactions in Moderna, Inc. stock. As of the latest transaction made, Swedbank Ab holds 85,099 shares of MRNA stock, worth $3.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
85,099
Previous 34,099 149.56%
Holding current value
$3.14 Million
Previous $4.05 Million 40.45%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$63.64 - $125.14 $3.25 Million - $6.38 Million
51,000 Added 149.56%
85,099 $5.69 Million
Q2 2024

Jul 18, 2024

BUY
$101.21 - $166.61 $302,921 - $498,663
2,993 Added 9.62%
34,099 $4.05 Million
Q1 2024

May 21, 2024

BUY
$85.37 - $115.44 $2.66 Million - $3.59 Million
31,106 New
31,106 $3.31 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Swedbank Ab Portfolio

Follow Swedbank Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.